Skye Bioscience Moves to Nasdaq, Hits Milestone in Clinical Program
–News Direct– Skye Bioscience CEO Punit Dhillon joined Steve Darling from Proactive to share news announcing the company's uplisting of its common stock to the Nasdaq stock exchange, trading under …
Skye Bioscience Moves to Nasdaq, Hits Milestone in Clinical Program Read More